Perrigo Puts Up $8.6B For Elan

Law360, New York (July 29, 2013, 11:52 AM EDT) -- Perrigo Co. has inked an $8.6 billion deal to buy Ireland-based drug company Elan Corp. PLC, opening the door to international expansion after emerging as the successful suitor in a string of attempted takeovers, it said Monday.

The acquisition clears up what has been a murky few months for Elan, amid a series of hostile bids by Royalty Pharma Inc. The cash-and-stock deal — which offers $6.7 billion for Elan’s shares at $16.50 each — will create a new company, Perrigo Company PLC, in Ireland, Perrigo...
To view the full article, register now.